https://www.selleckchem.com/pr....oducts/Staurosporine
The evaluation items were 30-day mortality, 30-day major amputation, prevention from distal embolization, and thrombus capture rate. The mean age was 74.4 ± 10.3 years, 53.2% were men, 55.8% were diabetic, and 9.1% were on hemodialysis. The mean lesion length was 199.5 ± 94.4 mm; 79.2% were class C/D lesions (TASC II classification). The 30-day mortality and major amputation rates were 1.9 and 1.0%, respectively. The rate of prevention of distal embolization or no-flow/slow-flow phenomenon was 93.4%. Capture of thrombus was observ
Like
Comment
Share
